Date | Detail |
---|---|
Sep 08, 2019 |
BeiGene Corporate Update Conference Call
|
Jun 20, 2019 |
BeiGene Clinical Data Update Mid-2019
|
Jun 12, 2019 |
BeiGene, Ltd. at the Goldman Sachs 40th Annual Global Healthcare Conference
|
Mar 13, 2019 |
BeiGene, Ltd. at the Barclay’s Global Healthcare Conference
|
Mar 11, 2019 |
BeiGene, Ltd. at the Cowen and Company 39th Annual Health Care Conference
|
Mar 01, 2019 |
BeiGene, Ltd. at the 8th Annual SVB Leerink Global Healthcare Conference
|
Feb 28, 2019 |
Hong Kong Investor Event
|
Feb 27, 2019 |
Q4 2018 BeiGene, Ltd. Earnings Conference Call
|
Feb 14, 2019 |
Guggenheim Healthcare Talks Idea Forum | Oncology Day
|
Dec 03, 2018 |
BeiGene Analyst and Investor Event
|
Nov 28, 2018 |
BeiGene, Ltd. at the 30th Annual Piper Jaffray Healthcare Conference
|
Oct 12, 2018 |
IWWM Oral Presentation on Zanubrutinib
|
Oct 03, 2018 |
BeiGene, Ltd. at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
|
Oct 02, 2018 |
BeiGene, Ltd. at the Ladenburg Thalmann 2018 Healthcare Conference
|
Sep 12, 2018 |
BeiGene, Ltd. at the Morgan Stanley 16th Annual Global Healthcare Conference
|
Jun 15, 2018 |
BeiGene, Ltd. at the 23rd Congress of the European Hematology Association (EHA)
|
Jun 12, 2018 |
BeiGene, Ltd. at the William Blair 2018 Growth Stock Conference
|
Jun 12, 2018 |
BeiGene, Ltd. at the Goldman Sachs 39th Annual Global Healthcare Conference
|
May 23, 2018 |
BeiGene, Ltd. at the UBS Global Healthcare Conference
|
May 08, 2018 |
BeiGene, Ltd. at the Deutsche Bank 43rd Annual Health Care Conference
|